F

Forty Seven Inc.

11 employees

Forty Seven is a clinical-stage immuno-oncology company that is developing therapies targeting cancer immune evasion pathways.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Immuno-Oncology and biotechnology
Health Care
Clinical Trials

Date founded

2015

Funding rounds raised

Total raised

$75M

from 8 investors over 8 rounds

F

Forty Seven Inc. raised $6M on August 7, 2019

Investors: The Leukemia & Lymphoma Society

F

Forty Seven Inc. raised $75M on October 17, 2017

Investors: Lightspeed Venture Partners, Clarus Ventures, LLC, Wellington Management and GV

F

Forty Seven Inc. raised $75M on February 25, 2016

Investors: GV, Lightspeed Venture Partners and Clarus Ventures, LLC

FAQ